Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.
Explore this paper's citation graph
Summary
In select patients, the natural history of this disease condition may be altered by using the multimodality approach of cytoreductive surgery and intraperitoneal hyperthermic chemotherapy, and these results require confirmation in prospective randomized studies.
- Type
- article
- Published
- 2003-01-01
- Cited by
- 221
- References
- 39
- OpenAlex
- https://openalex.org/W1986230033
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:24273432
Keywords
Medicine, Surgery, Peritoneal carcinomatosis, Hyperthermic intraperitoneal chemotherapy, Cytoreductive surgery
References
- Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors
- Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin.
- Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon.
- Selective lethal effect of supranormal temperatures on human neoplastic cells.
- Clinical delivery system for intraperitoneal hyperthermic chemotherapy.
- Differential response of normal and tumor microcirculation to hyperthermia.
- Karnofsky performance status revisited: reliability, validity, and guidelines.
- Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis
- Pentetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy
- Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival.
- Treatment of Primary Peritoneal Mesothelioma by Continuous Hyperthermic Peritoneal Perfusion (CHPP)
- Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy
- Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy
- Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.
- Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy
- Effects of antineoplastic agents and hyperthermia on cytotoxicity toward chronically hypoxic glioma cells.
- Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique
- Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination
- Role for Surgical Cytoreduction in Multimodality Treatments for Cancer
- Peritoneal carcinomatosis from non‐gynecologic malignancies
Cited by
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Small Bowel Adenocarcinoma
- Clinical research methodology in peritoneal surface oncology: a difficult challenge.
- The eligibility for local‐regional treatment of peritoneal surface malignancy
- Right Hemicolectomy is not Routinely Indicated in Pseudomyxoma Peritonei
- Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
- Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies.
- Patient selection for cytoreduction and hyperthermic intraperitoneal chemoperfusion.
- Sitilo experience on peritoneal carcinomatosis from colorectal cancer: clinical prognostic features.
- Tratamiento quirúrgico de las metástasis pulmonares
- Quimioterapia intraperitoneal hipertérmica con técnica cerrada y sistema de recirculación de CO2 para el tratamiento de carcinomatosis peritoneal
- A prospective evaluation of venous thromboembolism in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
- Advances in clinical research and management of diffuse peritoneal mesothelioma.
- Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion in the treatment of ovarian and peritoneal metastasis from breast carcinoma – a case report
- Optimierung der prophylaktischen Wirkung von Phospholipiden auf die Adhäsion von freien Kolonkarzinomzellen
- Study of the therapeutic effect of 188Re labeled folate targeting albumin nanoparticle coupled with cis-Diamminedichloroplatinum Cisplatin on human ovarian cancer
- Cancérologie digestive : pratiques chirurgicales
- The spectrum of pneumatosis intestinalis.
- Tratamiento regional de la enfermedad peritoneal maligna mediante citoreducción, quimioterapia intraperitoneal y perioperatoria: análisis de supervivencia y factores pronósticos
- The optimal starting time of postoperative intraperitoneal mitomycin-C therapy with preserved intestinal wound healing
- Klinisches Staging der Peritonealkarzinose durch Scoringsysteme
Related papers
- Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer
- Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis
- Long-term survival in patients with peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermi c intraperitoneal chemotherapy (HIPEC): ten-year experience from a single institution
- Intraoperative and postoperative effects of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: Results from a monocentric retrospective study
- The Effect of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Quality of Life in Colorectal Originated Peritoneal Carcinomatosis
- 306. Survival prognostic factors in patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery and intraoperative hyperthermic intreperitoneal chemotherapy – A single institution experience
- Mo1632 Readmission Following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis – Can We Predict (or Avoid) Them?
- 2195 Circulating tumor cells as biomarkers in patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC)
- Использование гипертермической интраперитонеальной перфузии химиопрепаратов и циторедуктивных операций при колоректальном и овариальном раке